Silke Sperling

Dr. Silke R. Sperling is a highly experienced professional with over 25 years of expertise in medicine, fundamental research, translation, and digitalization. She holds a medical degree and a habilitation in molecular biology and bioinformatics. Dr. Sperling has been a university professor at Charité for more than 13 years and previously led an interdisciplinary research group at the Max Planck Institute in Berlin, focusing on cardiovascular genetics. Throughout her career, she has actively collaborated with pioneering individuals on cutting-edge projects, often contributing to international scientific initiatives. Dr. Sperling is a firm believer in the effective translation of innovations into practical products to promote a healthy and fulfilling everyday life. With this vision, she offers guidance and invests in early-stage startups in the healthtech sector, particularly those aligned with digital innovations. Notably, she is a co-founder of Catalpa VC, an investment firm that supports innovative entrepreneurs and startups in the healthtech sector.